Center for Scientific Review; Notice of Closed Meeting, 68715 [2022-24950]
Download as PDF
<![CDATA[
68715
Federal Register / Vol. 87, No. 220 / Wednesday, November 16, 2022 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued
Number of
respondents 1
Form name
OPTN Membership Application for Lung Transplant Programs ................................................................................
OPTN Membership Application for Islet Transplant Programs 2 .............................................................................
OPTN Membership Application for Vascularized Composite Allograft (VCA) Transplant Programs ....................
OPTN Membership Application for Intestine Transplant
Programs ..........................................................................
OPTN Membership Application for Organ Procurement Organizations (OPOs) ..........................................................
OPTN Membership Application for Histocompatibility Laboratories ............................................................................
OPTN Representative Form ................................................
OPTN Medical/Scientific Membership Application ..............
OPTN Public Organization Membership Application ...........
OPTN Business Membership Application ............................
OPTN Individual Membership Application ...........................
OPTN Membership Application Surgeon or Physician
Log 3 .................................................................................
Primary Program Administrator Form ..................................
Primary Data Coordinator Form ..........................................
Additional Surgeon and Physician Request Form ...............
HOPE Act Variance Request Form 4 ...................................
Kidney Paired Donation Pilot Program (KPDPP) contact
update form ......................................................................
Total = 22 forms ...........................................................
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
72
0.64
47
9.00
423
19
0.00
0
5.00
0
43
0.98
43
15.50
667
21
0.19
4
11.00
44
57
0.14
8
40.00
320
141
1,760
10
7
11
8
0.21
0.02
0.30
0.57
0.55
0.88
30
36
3
4
7
8
2.50
0.25
0.75
0.50
0.88
0.25
75
9
3
2
7
2
0
1,562
1,760
1,562
68
0.00
0.05
0.03
0.08
0.00
0
79
53
125
0
0.00
0.25
0.13
1.17
1.33
0
20
7
147
0
159
0.33
53
1.63
87
8,153
........................
870
........................
5,699
1 The
numbers of respondents were updated with the data as of December 31, 2021, and reflect changes in members’ statuses.
were no Islet applications processed in 2021, hence no responses.
OPTN Membership Application Surgeon or Physician Log is an optional form. The information can also be submitted by the OPTN member using a different format. The burden to complete is built into the organ application data.
4 There were no HOPE Act Variance Request forms processed in 2021, hence no responses.
2 There
3 The
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Maria G. Button,
Director, Executive Secretariat.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Drug
Development.
Date: December 6, 2022.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maureen Shuh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–4097, maureen.shuh@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
[FR Doc. 2022–24926 Filed 11–15–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
VerDate Sep<11>2014
17:27 Nov 15, 2022
Jkt 259001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 10, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–24950 Filed 11–15–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\16NON1.SGM
16NON1
]]>Agencies
[Federal Register Volume 87, Number 220 (Wednesday, November 16, 2022)]
[Notices]
[Page 68715]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24950]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Drug Development.
Date: December 6, 2022.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maureen Shuh, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 480-4097,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: November 10, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-24950 Filed 11-15-22; 8:45 am]
BILLING CODE 4140-01-P
